Correction: The potential of Lisosan G as a possible treatment for glaucoma

There was a mistake in Figure 4A as published. A preliminary version of the panel shown in Figure 4A was included erroneously in the final version of the figure. The corrected Figure 4 appears below.

Six fluorescence microscopy panels labeled A to F show green-stained retinal ganglion cells in the center and periphery of retinas under three conditions: D2b, D2e, and D2 plus LG treatment. Panel G is a box plot comparing retinal ganglion cell densities (per square millimeter) in central and peripheral areas for each condition, showing significant differences with annotations of asterisks and dollar signs.

Baseline and endpoint densitometric analysis of RBPMS-immunostained RGCs in whole mount retinas. Immunofluorescence photomicrographs show representative RBPMS immunostaining in central and peripheral areas of D2b, (A,D), D2e (B,E) and D2+LG (C,F) retinas. Scale bar, 100 μm. (G) analysis of RBPMS positive cell density in D2b (gray boxes), D2e (white boxes), and D2+LG (dashed boxes) retinas. Box plots describe the statistical distribution of n = 4 independent retinas. Data were analyzed using two-way ANOVA with Bonferroni post-hoc test. *p < 0.05 vs. D2.

The original article has been updated.

StatementsGenerative AI statement

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords

inflammation, neuroprotection, nutraceuticals, oxidative stress, pattern electroretinogram

Citation

Amato R, Rossino MG, Cammalleri M, Timperio AM, Fanelli G, Dal Monte M, Pucci L and Casini G (2026) Correction: The potential of Lisosan G as a possible treatment for glaucoma. Front. Pharmacol. 17:1850441. doi: 10.3389/fphar.2026.1850441

Updates

Copyright

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Laura Pucci, ; Giovanni Casini,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Comments (0)

No login
gif